Company: HCTI
Filing Date: 2025-04-11
Form Type: 8-K
Source: 0001213900-25-030806
Chunk: 1

Company: Healthcare Triangle, Inc.
Filing Date: 2025-04-11
Form: 8-K
Item: Item 5.02
Chunk 1
---
 focus around software M& A and financial reporting. Mr. Ayanoglou had been, prior
to joining the Company, for over four years consulting variety of clients on several critical M& A transactions, corporate reporting
and CFO related matters in the technology and healthcare spaces. Prior to that, Mr. Ayanoglou was a Director of Valuations and Transaction
Support at Open Text where he served for over 13 years and participated in the execution of over 43 transactions where the deal sizes
ranged from $5M to $1.62B (including acquisition of divisions of Dell/EMC). Three of the deals that Mr. Ayanoglou executed on were greater
than $1B, increasing over time Open Text’s valuation to over $11 billion (during their tenure). Mr. Ayanoglou also has held senior
finance roles in external reporting for a large SEC filer, and audit & assurance at KPMG LLP. Mr. Ayanoglou is a graduate of the
University of Toronto (Rotman School of Business), a CPA, Chartered Accountant and a Chartered Business Valuator.

There are no arrangements or understandings between
Mr. Ayanoglou and any other persons pursuant to which they were selected as an officer of the Company, and Mr. Ayanoglou are not related
to any other executive officer or director of the Company.

The foregoing description of the Employment Agreement
does not purport to be complete and is qualified in its entirety by reference to the Employment Agreement, a copy of which is filed as
Exhibit 10.1 hereto and incorporated by reference into this Item 5.02.

Resignation of Director

On April 10, 2025, Mr. Shibu Kizhakevilayil resigned
as a director of the Company, effective immediately. Mr. Kizhakevilayil did not resign as a result of any disagreement with
the Company or any matter relating to the Company’s operations, policies or practices.

Appointment of Director

On April 10, 2025, the Board appointed Ms. Sujatha
Ramesh as an executive director of the Company, along with their current role as the Chief Operating Officer of the Company.

As disclosed in the Company’s
current report, filed with the SEC on March 24, 2025, Ms. Ramesh, age 54, has a distinguished career of over 25 years of senior executive
experience in